These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The validity and significance of substage IIIC by node involvement in epithelial ovarian cancer: impact of nodal metastasis on patient survival. Kanazawa K, Suzuki T, Tokashiki M. Gynecol Oncol; 1999 May; 73(2):237-41. PubMed ID: 10329040 [Abstract] [Full Text] [Related]
3. The addition of extensive upper abdominal surgery to achieve optimal cytoreduction improves survival in patients with stages IIIC-IV epithelial ovarian cancer. Eisenhauer EL, Abu-Rustum NR, Sonoda Y, Levine DA, Poynor EA, Aghajanian C, Jarnagin WR, DeMatteo RP, D'Angelica MI, Barakat RR, Chi DS. Gynecol Oncol; 2006 Dec; 103(3):1083-90. PubMed ID: 16890277 [Abstract] [Full Text] [Related]
4. Role of lymphadenectomy in the management of grossly apparent advanced stage epithelial ovarian cancer. Aletti GD, Dowdy S, Podratz KC, Cliby WA. Am J Obstet Gynecol; 2006 Dec; 195(6):1862-8. PubMed ID: 17132488 [Abstract] [Full Text] [Related]
5. The potential therapeutic role of lymph node resection in epithelial ovarian cancer: a study of 13918 patients. Chan JK, Urban R, Hu JM, Shin JY, Husain A, Teng NN, Berek JS, Osann K, Kapp DS. Br J Cancer; 2007 Jun 18; 96(12):1817-22. PubMed ID: 17519907 [Abstract] [Full Text] [Related]
7. Is complete surgical staging necessary in patients with stage I mucinous epithelial ovarian tumors? Cho YH, Kim DY, Kim JH, Kim YM, Kim KR, Kim YT, Nam JH. Gynecol Oncol; 2006 Dec 18; 103(3):878-82. PubMed ID: 16859736 [Abstract] [Full Text] [Related]
8. Optimal debulking surgery is an independent prognostic factor in patients with FIGO IIIC primary epithelial ovarian carcinoma. Wang PH, Yuan CC, Shyong WY, Chiang SC, Chao JY, Yen MS, Ng HT. Zhonghua Yi Xue Za Zhi (Taipei); 2000 Mar 18; 63(3):220-5. PubMed ID: 10746418 [Abstract] [Full Text] [Related]
13. Lymph node metastasis in stage I epithelial ovarian cancer. Suzuki M, Ohwada M, Yamada T, Kohno T, Sekiguchi I, Sato I. Gynecol Oncol; 2000 Nov 18; 79(2):305-8. PubMed ID: 11063662 [Abstract] [Full Text] [Related]
15. Second-look laparotomy after modified posterior exenteration: patterns of persistence and recurrence in patients with stage III and stage IV ovarian cancer. Spirtos NM, Eisenkop SM, Schlaerth JB, Ballon SC. Am J Obstet Gynecol; 2000 Jun 18; 182(6):1321-7. PubMed ID: 10871445 [Abstract] [Full Text] [Related]
17. Significance of preoperative serum CA-125 levels in the prediction of lymph node metastasis in epithelial ovarian cancer. Kim HS, Park NH, Chung HH, Kim JW, Song YS, Kang SB. Acta Obstet Gynecol Scand; 2008 Aug 18; 87(11):1136-42. PubMed ID: 18951217 [Abstract] [Full Text] [Related]
18. Association of lymphadenectomy and survival in stage I ovarian cancer patients. Chan JK, Munro EG, Cheung MK, Husain A, Teng NN, Berek JS, Osann K. Obstet Gynecol; 2007 Jan 18; 109(1):12-9. PubMed ID: 17197582 [Abstract] [Full Text] [Related]
20. Does systematic lymphadenectomy have a benefit on survival of suboptimally debulked patients with stage III ovarian carcinoma? A DEGOG* Study. Saygili U, Guclu S, Uslu T, Erten O, Ture S, Demir N. J Surg Oncol; 2002 Nov 18; 81(3):132-7. PubMed ID: 12407725 [Abstract] [Full Text] [Related] Page: [Next] [New Search]